Gregory Mann+FollowQuantum BioPharma’s Crypto Power MoveHeard the buzz? Quantum BioPharma just tossed another $1M into Bitcoin, bumping its crypto stash to $4.5M—and the stock jumped nearly 20%! The company’s basically hedging its bets against wild currency swings, hoping to keep your investment safer and maybe even score some extra gains. Retail investors are hyped, calling it an under-the-radar gem. If you like a little crypto with your biotech, this one’s worth a peek! #stocks #crypto #investing #biotech #moneyhacks #Business00Share
Jacqueline Howard DDS+FollowAstraZeneca’s Cancer Drug Scores Big!AstraZeneca just dropped some major news—its cancer drug Imfinzi, when paired with standard therapy, helped high-risk bladder cancer patients stay cancer-free longer! No new safety issues popped up, and patients could stick with their treatments. Imfinzi’s already a big deal for other cancers, but this new data could mean even more approvals. No wonder AZN stock is getting a little love today! Anyone else watching this stock now? #AstraZeneca #Imfinzi #CancerResearch #Biotech #StockMarket #Health252Share
Aaron Rodriguez+FollowBioNTech’s Big Cancer Drug MoveBioNTech is making waves again—this time, they’re prepping to file for approval of their first cancer drug, BNT323, by the end of 2024. But with all the tariff drama and global supply chain jitters, they’re not taking any chances: BioNTech’s diversifying its suppliers so they’re not just relying on China. Plus, they’re sitting on a massive cash pile from their COVID-19 vaccine days, fueling even more cancer research. New CFO incoming, too! #BioNTech #CancerResearch #PharmaNews #DrugApproval #Biotech #Health110Share
olee+FollowWould You Trust a Fingernail Selfie for Health?Sanguina just rebranded its AnemoCheck Mobile app as Ruby, and it’s not just about anemia anymore. Ruby now uses your smartphone camera to analyze your fingernails for both iron and circulation scores, promising a full blood health check from home. But can a selfie really replace traditional lab tests? Is this the future of health monitoring, or are we trading accuracy for convenience? Let’s debate: would you trust your wellness to an app like Ruby? #DigitalHealth #HealthTech #MobileInnovation #WellnessApps #Biotech #Tech90Share
Joseph Bradley+FollowCancer Breakthrough? TARA-002's Wild ResultsJust heard about a new cancer drug, TARA-002, that's making waves in bladder cancer trials. Some patients saw a 100% complete response rate—yep, you read that right! Even better, the side effects were mostly mild and short-lived. Docs are hyped because this could mean fewer people needing drastic surgeries. If the next round of results holds up, this could be a game-changer for cancer treatment. Keep your eyes on this one! #CancerResearch #MedicalBreakthrough #BladderCancer #Biotech #HealthNews #Health2094Share
Amanda Crosby+FollowAre Drug Tests Missing Brain Risks?Ever wondered if your meds are as safe as they seem? The new 'patients-on-a-chip' tech just revealed that some drugs, once processed by the liver, can become way more toxic to our brains than anyone thought. Troglitazone, for example, hit nearly 7 times more genes in brain cells after liver metabolism. Should drug safety tests always include multi-organ models, or is this overkill? Curious to hear your take! #DrugSafety #Neurotoxicity #Biotech #FutureOfMedicine #TechDebate #Tech241Share
